Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
14 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to GRI Bio, Inc.’s names, not what it holds today.
Patents granted
14
14 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 2 in 2023
Applications published
11
since 2001, to Dec 31, 2025
Names they are printed under
4
its own name, a former name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals6
Organic fine chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
GRI BIO, INC. its own name
US, as the owner printed on each patent
0 publishedGRI BIO, INC. its own name
named as the applicant on its applications, in US
9 publishedVallon Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
0 publishedVallon Pharmaceuticals, Inc. a former name
named as the applicant on its applications, in US
2 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 30, 2023 | 11,660,309 | Prevention and treatment of inflammatory conditions | Pharmaceuticals | GRI BIO, INC. |
| Jan 31, 2023 | 11,564,895 | Hydroxy-substituted amino and ammonium derivatives and their medical use | Pharmaceuticals | GRI BIO, INC. |
| Dec 6, 2022 | 11,517,537 | Abuse deterrent formulations of amphetamine | Pharmaceuticals | Vallon Pharmaceuticals, Inc. |
| Sep 27, 2022 | 11,453,642 | Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | Organic fine chemistry | GRI BIO, INC. |
| Feb 22, 2022 | 11,253,490 | Compositions and methods of treating cognitive impairment | Pharmaceuticals | Vallon Pharmaceuticals, Inc. |
| Mar 23, 2021 | 10,952,977 | Hydroxy-substituted amino and ammonium derivatives and their medical use | Pharmaceuticals | GRI BIO, INC. |
| Feb 23, 2021 | 10,925,886 | Prevention and treatment of inflammatory conditions | Pharmaceuticals | GRI BIO, INC. |
| Nov 10, 2020 | 10,829,506 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | Pharmaceuticals | GRI BIO, INC. |
| Oct 27, 2020 | 10,815,195 | Oxygenated amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | Organic fine chemistry | GRI BIO, INC. |
| Nov 12, 2019 | 10,471,015 | Abuse deterrent formulations of amphetamine | Pharmaceuticals | Vallon Pharmaceuticals, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Aug 24, 2023 | 2023/0265052 | OXYGENATED AND AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | Organic fine chemistry | GRI BIO, INC. |
| Jul 29, 2021 | 2021/0228510 | HYDROXY-SUBSTITUTED AMINO AND AMMONIUM DERIVATIVES AND THEIR MEDICAL USE | Pharmaceuticals | GRI BIO, INC. · patent 11,564,895 granted from it |
| Jun 10, 2021 | 2021/0169909 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | Pharmaceuticals | GRI BIO, INC. · patent 11,660,309 granted from it |
| Apr 22, 2021 | 2021/0114979 | OXYGENATED AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | Organic fine chemistry | GRI BIO, INC. · patent 11,453,642 granted from it |
| Mar 19, 2020 | 2020/0085752 | ABUSE DETERRENT FORMULATIONS OF AMPHETAMINE | Pharmaceuticals | Vallon Pharmaceuticals, Inc. · patent 11,517,537 granted from it |
| Jun 13, 2019 | 2019/0175529 | HYDROXY-SUBSTITUTED AMINO AND AMMONIUM DERIVATIVES AND THEIR MEDICAL USE | Pharmaceuticals | GRI BIO, INC. · patent 10,952,977 granted from it |
| Mar 14, 2019 | 2019/0076367 | ABUSE DETERRENT FORMULATIONS OF AMPHETAMINE | Pharmaceuticals | Vallon Pharmaceuticals, Inc. · patent 10,471,015 granted from it |
| Aug 30, 2018 | 2018/0244703 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | Pharmaceuticals | GRI BIO, INC. · patent 10,829,506 granted from it |
| Jul 12, 2018 | 2018/0193368 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | Pharmaceuticals | GRI BIO, INC. · patent 10,925,886 granted from it |
| Dec 28, 2017 | 2017/0369430 | OXYGENATED AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | Organic fine chemistry | GRI BIO, INC. · patent 10,815,195 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.